Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

GZ-793A

Product Specifications

UNSPSC Description

GZ-793A is an orally active and selective vesicular monoamine transporter-2 (VMAT2) inhibitor, with an Ki of 0.029 μM. GZ-793A inhibits the neurochemical effects of methamphetamine (METH)-induced dopamine release. GZ-793A can be used for research of METH addiction[1][2][3].

Target Antigen

Monoamine Transporter

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/gz-793a.html

Purity

99.50

Solubility

H2O : 3 mg/mL (ultrasonic;warming)

Smiles

OC[C@H](O)CN1[C@H](CCC[C@H]1CCC2=CC=C(C=C2)OC)CCC3=CC=C(C=C3)OC.Cl

Molecular Weight

464.04

References & Citations

[1]Wilmouth CE, et al. Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats. Pharmacol Biochem Behav. 2013 Nov;112:29-33.|[2]Nickell JR, et al. GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2. Eur J Pharmacol. 2017 Jan 15;795:143-149.|[3]Nickell JR, et al. The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. Adv Pharmacol. 2014;69:71-106.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-117883/GZ-793A-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-117883/GZ-793A-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

CAS Number

1356447-90-9

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cyanidin3-glucopyranosyl- (1-6) -[3-xylopyranosyl- (1-2) ]-galactopyranoside
M39726-01 100 mg

Cyanidin3-glucopyranosyl- (1-6) -[3-xylopyranosyl- (1-2) ]-galactopyranoside

Ask
View Details
Cyanidin3-glucopyranosyl- (1-6) -[3-xylopyranosyl- (1-2) ]-galactopyranoside
M39726-02 25 mg

Cyanidin3-glucopyranosyl- (1-6) -[3-xylopyranosyl- (1-2) ]-galactopyranoside

Ask
View Details
Cyanidin3-glucopyranosyl- (1-6) -[3-xylopyranosyl- (1-2) ]-galactopyranoside
M39726-03 50 mg

Cyanidin3-glucopyranosyl- (1-6) -[3-xylopyranosyl- (1-2) ]-galactopyranoside

Ask
View Details
CD72.1 antibody (FITC)
MBS5318206-01 0.5 mg

CD72.1 antibody (FITC)

Ask
View Details
CD72.1 antibody (FITC)
MBS5318206-02 5x 0.5 mg

CD72.1 antibody (FITC)

Ask
View Details
pECMV-DDOST-3 Plasmid
PVT14761 2 µg

pECMV-DDOST-3 Plasmid

Ask
View Details